Research

As a top research school, the University of Maryland School of Pharmacy applies an integrative approach to drug discovery and development, innovative patient care, and drug outcomes and their economic impact. Researchers in the Department of Pharmaceutical Sciences are identifying new drugs to treat drug abuse, cancer, neurodegenerative diseases, and infection. The Department Pharmacy Practice and Sciences focuses on clinical research and is creating innovative programs to improve health care at lower costs by having pharmacists provide step-by-step guidance in medication adherence and lifestyle changes to patients with chronic diseases such as diabetes. Researchers in the Department of Pharmaceutical Health Services Research are providing valuable information on the economic costs and public policy issues that arise once drugs and therapies have been made available to the public.

	The Retirement Research Foundation has awarded Linda Simoni-Wastila, Ph.D. from the Department of Pharmaceutical Health Services Research, $207,472 for her research into the quality of medication use in long-term facilities.
	Francoise Pradel, Ph.D. also in PHSR has recently received $33,105 from SNBL Clinical Pharmacology for a label comprehension assessment of an emergency use prototype household antibiotic kit.
	Dr. Stephen Hoag in the Department of Pharmaceutical Sciences (PSC) has received a $168,000 contract from the FDA to provide a Quality-by-Design approach for an immediate release tablet dosage.